Alert detail
LCD L39919: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms — Palmetto GBA
What changed
New LCD may affect billing for specific myeloproliferative tests.
Who’s affected: Hematology billing teams · Effective: August 17, 2025
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 15 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.